Evidence map›Paper›PMID 33926138›Full record

ArticleCancers2021

The Role of Pathological Method and Clearance Definition for the Evaluation of Margin Status after Pancreatoduodenectomy for Periampullary Cancer. Results of a Multicenter Prospective Randomized Trial.

Gennaro Nappo, Domenico Borzomati, Alessandro Zerbi, Paola Spaggiari, Ugo Boggi, Daniela Campani, Sławomir Mrowiec, Łukasz Liszka, Alessandro Coppola, Michela Amato and 6 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Gennaro NappoPancreatic Surgery Unit, Humanitas Clinical and Research Center-IRCCS, Via Manzoni 56, 20089 Rozzano, Italy.
Domenico BorzomatiDepartment of Surgery, Università Campus Bio-Medico di Roma, 00128 Rome, Italy.
Alessandro ZerbiPancreatic Surgery Unit, Humanitas Clinical and Research Center-IRCCS, Via Manzoni 56, 20089 Rozzano, Italy.
Paola SpaggiariPathology Unit, Humanitas Clinical and Research Center-IRCCS, Via Manzoni 56, 20089 Rozzano, Italy.
Ugo BoggiPathology Unit, Humanitas Clinical and Research Center-IRCCS, Via Manzoni 56, 20089 Rozzano, Italy.ORCID 0000-0002-7505-5896
Daniela CampaniPathology Unit, Azienda Ospedaliero-Universitaria Pisana, University of Pisa, 56126 Pisa, Italy.
Sławomir MrowiecDepartment of Gastrointestinal Surgery, Medical University of Silesia, 40-055 Katowice, Poland.
Łukasz LiszkaDepartment of Pathomorphology and Molecular Diagnostics, Medical University of Silesia, 40-055 Katowice, Poland.ORCID 0000-0001-6912-224X
Alessandro CoppolaDepartment of Surgery, Università Campus Bio-Medico di Roma, 00128 Rome, Italy.ORCID 0000-0002-5550-1756
Michela AmatoPathology Unit, Campus Bio-Medico University of Rome, 00128 Rome, Italy.
Tommasangelo PetittiDepartment of Public Health, Hygiene and Statistics, Campus Bio-Medico University of Rome, 00128 Rome, Italy.
Fabio VistoliPathology Unit, Humanitas Clinical and Research Center-IRCCS, Via Manzoni 56, 20089 Rozzano, Italy.ORCID 0000-0003-2115-4191
Marco MontorsiDepartment of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20090 Milan, Italy.ORCID 0000-0002-3887-3451
Giuseppe PerronePathology Unit, Campus Bio-Medico University of Rome, 00128 Rome, Italy.
Roberto CoppolaDepartment of Surgery, Università Campus Bio-Medico di Roma, 00128 Rome, Italy.ORCID 0000-0001-5798-0714
Damiano CaputoDepartment of Surgery, Università Campus Bio-Medico di Roma, 00128 Rome, Italy.ORCID 0000-0001-7058-1945
Università Campus Bio-Medico · ITHumanitas University · ITUniversity of Pisa · ITMedical University of Silesia · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere is extreme heterogeneity in the available literature on the determination of R1 resection rate after pancreatoduodenectomy (PD); consequently, its prognostic role is still debated. The aims of this multicenter randomized study were to evaluate the effect of sampling and clearance definition in determining R1 rate after PD for periampullary cancer and to assess the prognostic role of R1 resection.

methodsPD specimens were randomized to Leeds Pathology Protocol (LEEPP) (group A) or the conventional method adopted before the study (group B). R1 rate was determined by adopting 0- and 1-mm clearance; the association between R1, local recurrence (LR) and overall survival (OS) was also evaluated.

resultsOne-hundred-sixty-eight PD specimens were included. With 0 mm clearance, R1 rate was 26.2% and 20.2% for groups A and B, respectively; with 1 mm, R1 rate was 60.7% and 57.1%, respectively (

conclusionsThe 1 mm clearance is the most effective factor in determining the R1 rate after PD. However, the pathological method is crucial to accurately evaluate its prognostic role: only R1 resections obtained with the adoption of LEEPP seem to significantly affect prognosis.

Indexed as

margin statusmicroscopic residual tumorminimum clearancepancreatoduodenectomypathological evaluationR1 resection

Identifiers

PMID33926138
PMCPMC8123600
OpenAlexW3159019683

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.